8 Months
Novartis
Evolving their risk and compliance digital tool to ensure their pharmaceutical practices are ethical, compliant, globally consistent and smarter.
The Challenge:
Novartis is a global healthcare company based in Switzerland with the ambition to be the most valued and trusted medicines company in the world.
The Risk and Compliance department needed a much overdue update and digitisation of their current process to approve and ensure the overall company’s actions were ethical.
The Deliverables:
Product strategy: Overall Vision, User Benefits, Features
User testing research
Interactive Prototype
Desktop/Tablet high fidelity wireframes and UI Direction
Current
Tool
Pain Points:
Current Journey
Too time consuming.
Very manual and repetitious with data input.
All risk levels are treated equally.
Meaning approval for a low risk level request would take just as long for a high risk requestNo repository for information or guidance.
Individual country teams have had to take their own initiatives to create and store their own guidance.
User Insights
What mattered to users:
Requests submitted and approved quickly.
The ability to submit and have their requests approved as quick and efficiently as possible as to not delay their planned events and activities.
Accessing and digesting the right information.
The ability to access information and understand the risks involved easily and efficiently.
Improving
the Journey
Mapping the Product Vision
With the Core Team, we distilled a north star vision that we could continuously use to guide product features discussions later on.
Key Stakeholders Alignment Workshop
18 Global Stakeholders
Alignment
Prioritisation
Features mapping
Feasibility testing
Mapping the new user journey and flow
Initial wire-framing based on existing user insights
This was used to gather initial feedback from the core team and a few users to ensure we were heading in the right direction.
This process was iterative. We we wanted to ensure key information was digestible and pragmatic to the users.
